Testimony at the FDA’s Public Meeting Regarding Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027 April 19, 2022
Letter to the FDA Criticizing the Agency’s Response to Public Citizen’s Report on Implanted Spinal Cord Stimulators for Pain Relief July 29, 2020
Letter to Congress Offering Health Care-Related Reforms for Possible Inclusion in Future Cures 2.0 Legislation December 16, 2019
Letter to the FDA Urging the Agency Not to Approve the De Novo Premarket Application for neuroAD Therapy System for the Treatment of Alzheimer’s Dementia April 9, 2019
Testimony Before the FDA’s General and Plastic Surgery Devices Panel Regarding Breast Implants March 26, 2019
Testimony Before the FDA’s Obstetrics and Gynecology Devices Panel Regarding Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse February 12, 2019